Table 1.
Main CLSI recommendations for analysis and presentation of cAST data.
Fig 1.
Resistance estimates dependent on the handling of screening isolates.
Resistance rates were calculated either with inclusion (black columns) or exclusion (grey columns) of screening isolates, as described in the text. Further details are given in the supporting information (S1 Table).
Fig 2.
Resistance estimates dependent on the method of duplicate isolate removal.
Resistance rates were calculated using different methods of duplicate isolate removal, as described in the text. Further details are given in the supporting information (S2 Table).
Fig 3.
Resistance estimates dependent on the time-point of isolate recovery.
Resistance rates were calculated with respect to early isolates (black columns) or late isolates (grey columns), as described in the text. Further details are given in the supporting information (S3 Table).
Fig 4.
Resistance estimates dependent on the patient location.
Resistance rates were calculated with data stratification according to the patient location (hospital and ward), as described in the text. Further details are given in the supporting information (S4 Table).
Fig 5.
Resistance estimates dependent on the specimen type.
Resistance rates were calculated with data stratification according to the specimen type (black columns: isolates recovered from blood cultures, grey columns: isolates recovered from other body sites), as described in the text. Further details are given in the supporting information (S5 Table).
Fig 6.
Resistance estimates dependent on organism’s resistance characteristics.
Resistance rates were calculated with data stratification according to cefotaxime-resistance (all isolates: dark grey columns, only resistant strains: black columns, only susceptible strains: light grey columns), as described in the text. Further details are given in the supporting information (S6 Table).